VMD Financial Statements

Balance sheet, income statement, cash flow, and dividends for Viemed Healthcare Inc (VMD).


$312.27M Market Cap.

As of 03/10/2025 5:00 PM ET (MRY) • Disclaimer

VMD Market Cap. (MRY)


VMD Shares Outstanding (MRY)


VMD Assets (MRY)


Total Assets

$177.07M

Total Liabilities

$43.77M

Total Investments

$2.79M

VMD Income (MRY)


Revenue

$224.26M

Net Income

$11.27M

Operating Expense

$115.30M

VMD Cash Flow (MRY)


CF Operations

$39.09M

CF Investing

-$30.70M

CF Financing

-$3.69M

VMD Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

VMD Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$177,069,000 (14.32%)

$154,895,000 (32.34%)

$117,043,000 (-0.78%)

$117,962,000 (4.80%)

Assets Current

$52,880,000 (37.83%)

$38,367,000 (-3.46%)

$39,742,000 (-16.00%)

$47,310,000 (0.29%)

Assets Non-Current

$124,189,000 (6.57%)

$116,528,000 (50.75%)

$77,301,000 (9.41%)

$70,652,000 (8.06%)

Goodwill & Intangible Assets

$33,837,000 (11.56%)

$30,332,000 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$131,393,000 (15.36%)

$113,895,000 (17.30%)

$97,094,000 (2.40%)

$94,820,000 (16.07%)

Property Plant & Equipment Net

$79,160,000 (3.00%)

$76,852,000 (12.30%)

$68,437,000 (8.90%)

$62,846,000 (14.15%)

Cash & Equivalents

$17,540,000 (36.62%)

$12,839,000 (-24.09%)

$16,914,000 (-40.46%)

$28,408,000 (-8.31%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

-$278,000 (38.36%)

Deferred Revenue

$6,694,000 (7.85%)

$6,207,000 (34.23%)

$4,624,000 (23.21%)

$3,753,000 (10.09%)

Total Investments

$2,794,000 (-28.34%)

$3,899,000 (-6.16%)

$4,155,000 (92.63%)

$2,157,000 (194.27%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$2,794,000 (-28.34%)

$3,899,000 (-6.16%)

$4,155,000 (92.63%)

$2,157,000 (194.27%)

Inventory

$4,320,000 (-6.66%)

$4,628,000 (29.49%)

$3,574,000 (45.46%)

$2,457,000 (6.36%)

Trade & Non-Trade Receivables

$24,911,000 (35.01%)

$18,451,000 (19.98%)

$15,379,000 (19.93%)

$12,823,000 (3.64%)

Trade & Non-Trade Payables

$5,322,000 (27.32%)

$4,180,000 (57.74%)

$2,650,000 (-18.18%)

$3,239,000 (54.53%)

Accumulated Retained Earnings (Deficit)

$89,691,000 (12.83%)

$79,495,000 (13.81%)

$69,846,000 (-4.76%)

$73,335,000 (11.72%)

Tax Assets

$8,398,000 (84.25%)

$4,558,000 (44.93%)

$3,145,000 (-52.92%)

$6,680,000 (-23.51%)

Tax Liabilities

$3,883,000 (80.35%)

$2,153,000 (0%)

$0 (0%)

$0 (0%)

Total Debt

$6,866,000 (-33.49%)

$10,324,000 (1387.61%)

$694,000 (-89.35%)

$6,518,000 (-41.46%)

Debt Current

$1,270,000 (-36.69%)

$2,006,000 (305.25%)

$495,000 (-74.54%)

$1,944,000 (-57.53%)

Debt Non-Current

$5,596,000 (-32.72%)

$8,318,000 (4079.90%)

$199,000 (-95.65%)

$4,574,000 (-30.25%)

Total Liabilities

$43,768,000 (6.75%)

$41,000,000 (105.52%)

$19,949,000 (-13.80%)

$23,142,000 (-25.03%)

Liabilities Current

$37,326,000 (16.19%)

$32,124,000 (70.32%)

$18,861,000 (5.90%)

$17,811,000 (-22.62%)

Liabilities Non-Current

$6,442,000 (-27.42%)

$8,876,000 (715.81%)

$1,088,000 (-79.59%)

$5,331,000 (-32.09%)

VMD Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$224,257,000 (22.54%)

$183,008,000 (31.82%)

$138,832,000 (18.60%)

$117,062,000 (-10.85%)

Cost of Revenue

$91,054,000 (29.66%)

$70,225,000 (29.68%)

$54,152,000 (24.05%)

$43,652,000 (-14.74%)

Selling General & Administrative Expense

$106,199,000 (20.84%)

$87,884,000 (28.94%)

$68,161,000 (24.17%)

$54,893,000 (3.91%)

Research & Development Expense

$3,068,000 (10.28%)

$2,782,000 (3.19%)

$2,696,000 (27.77%)

$2,110,000 (94.83%)

Operating Expenses

$115,303,000 (17.11%)

$98,453,000 (28.82%)

$76,428,000 (23.61%)

$61,830,000 (15.94%)

Interest Expense

$776,000 (83.02%)

$424,000 (115.23%)

$197,000 (-38.05%)

$318,000 (-37.52%)

Income Tax Expense

$4,761,000 (14.78%)

$4,148,000 (49.86%)

$2,768,000 (-18.03%)

$3,377,000 (165.36%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$11,409,000 (11.38%)

$10,243,000 (64.63%)

$6,222,000 (-31.82%)

$9,126,000 (-71.06%)

Net Income to Non-Controlling Interests

$144,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$11,265,000 (9.98%)

$10,243,000 (64.63%)

$6,222,000 (-31.82%)

$9,126,000 (-71.06%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$11,265,000 (9.98%)

$10,243,000 (64.63%)

$6,222,000 (-31.82%)

$9,126,000 (-71.06%)

Weighted Average Shares

$38,754,893 (1.05%)

$38,354,071 (-0.78%)

$38,655,403 (-2.12%)

$39,491,117 (1.93%)

Weighted Average Shares Diluted

$40,805,085 (1.06%)

$40,378,922 (1.44%)

$39,807,434 (-2.15%)

$40,680,947 (0.38%)

Earning Before Interest & Taxes (EBIT)

$16,802,000 (13.41%)

$14,815,000 (61.26%)

$9,187,000 (-28.34%)

$12,821,000 (-52.29%)

Gross Profit

$133,203,000 (18.11%)

$112,783,000 (33.19%)

$84,680,000 (15.35%)

$73,410,000 (-8.36%)

Operating Income

$17,900,000 (24.91%)

$14,330,000 (73.65%)

$8,252,000 (-28.74%)

$11,580,000 (-56.76%)

VMD Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$30,699,000 (41.09%)

-$52,113,000 (-117.35%)

-$23,976,000 (-21.42%)

-$19,746,000 (-134.65%)

Net Cash Flow from Financing

-$3,689,000 (-230.54%)

$2,826,000 (118.51%)

-$15,266,000 (-186.90%)

-$5,321,000 (41.33%)

Net Cash Flow from Operations

$39,089,000 (-13.54%)

$45,212,000 (62.94%)

$27,748,000 (23.36%)

$22,494,000 (-35.93%)

Net Cash Flow / Change in Cash & Cash Equivalents

$4,701,000 (215.36%)

-$4,075,000 (64.55%)

-$11,494,000 (-346.72%)

-$2,573,000 (-114.60%)

Net Cash Flow - Business Acquisitions and Disposals

-$2,999,000 (89.51%)

-$28,588,000 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$250,000 (-1150.00%)

-$20,000 (99.07%)

-$2,141,000 (-257.43%)

-$599,000 (4.77%)

Capital Expenditure

-$27,450,000 (-16.78%)

-$23,505,000 (-7.65%)

-$21,835,000 (-14.04%)

-$19,147,000 (-145.92%)

Issuance (Repayment) of Debt Securities

-$3,601,000 (-270.10%)

$2,117,000 (136.26%)

-$5,838,000 (-45.99%)

-$3,999,000 (63.46%)

Issuance (Purchase) of Equity Shares

-$52,000 (-107.33%)

$709,000 (107.52%)

-$9,428,000 (-613.16%)

-$1,322,000 (-170.47%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$6,285,000 (7.45%)

$5,849,000 (12.44%)

$5,202,000 (1.01%)

$5,150,000 (5.49%)

Depreciation Amortization & Accretion

$25,368,000 (16.04%)

$21,862,000 (39.87%)

$15,630,000 (38.17%)

$11,312,000 (18.05%)

VMD Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

59.40% (-3.57%)

61.60% (0.98%)

61.00% (-2.71%)

62.70% (2.79%)

Profit Margin

5.00% (-10.71%)

5.60% (24.44%)

4.50% (-42.31%)

7.80% (-67.50%)

EBITDA Margin

18.80% (-6.00%)

20.00% (11.73%)

17.90% (-13.11%)

20.60% (-25.90%)

Return on Average Equity (ROAE)

9.20% (-4.17%)

9.60% (50.00%)

6.40% (-33.33%)

9.60% (-75.13%)

Return on Average Assets (ROAA)

6.80% (-4.23%)

7.10% (33.96%)

5.30% (-31.17%)

7.70% (-72.50%)

Return on Sales (ROS)

7.50% (-7.41%)

8.10% (22.73%)

6.60% (-40.00%)

11.00% (-46.34%)

Return on Invested Capital (ROIC)

17.30% (2.37%)

16.90% (50.89%)

11.20% (-31.71%)

16.40% (-57.51%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

27.66 (-4.88%)

29.07 (-38.47%)

47.25 (108.19%)

22.7 (136.91%)

Price to Sales Ratio (P/S)

1.39 (-15.74%)

1.65 (-21.85%)

2.1 (19.53%)

1.76 (-23.10%)

Price to Book Ratio (P/B)

2.38 (-10.40%)

2.65 (-10.37%)

2.96 (35.66%)

2.18 (-41.31%)

Debt to Equity Ratio (D/E)

0.33 (-7.50%)

0.36 (75.61%)

0.2 (-15.98%)

0.24 (-35.45%)

Earnings Per Share (EPS)

0.29 (7.41%)

0.27 (68.75%)

0.16 (-30.43%)

0.23 (-71.60%)

Sales Per Share (SPS)

5.79 (21.27%)

4.77 (32.85%)

3.59 (21.19%)

2.96 (-12.54%)

Free Cash Flow Per Share (FCFPS)

0.3 (-47.00%)

0.57 (269.93%)

0.15 (80.00%)

0.09 (-87.94%)

Book Value Per Share (BVPS)

3.39 (14.14%)

2.97 (18.23%)

2.51 (4.62%)

2.4 (13.85%)

Tangible Assets Book Value Per Share (TABVPS)

3.7 (13.79%)

3.25 (7.27%)

3.03 (1.37%)

2.99 (2.82%)

Enterprise Value Over EBIT (EV/EBIT)

18 (-10.00%)

20 (-31.03%)

29 (93.33%)

15 (36.36%)

Enterprise Value Over EBITDA (EV/EBITDA)

7.31 (-11.53%)

8.26 (-24.28%)

10.91 (40.36%)

7.77 (-0.45%)

Asset Turnover

1.35 (6.48%)

1.27 (6.75%)

1.19 (19.56%)

0.99 (-15.00%)

Current Ratio

1.42 (18.68%)

1.19 (-43.33%)

2.11 (-20.67%)

2.66 (29.56%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$11,639,000 (-46.38%)

$21,707,000 (267.11%)

$5,913,000 (76.67%)

$3,347,000 (-87.75%)

Enterprise Value (EV)

$308,182,227 (1.72%)

$302,959,658 (11.90%)

$270,731,311 (44.33%)

$187,571,928 (-34.09%)

Earnings Before Tax (EBT)

$16,026,000 (11.36%)

$14,391,000 (60.08%)

$8,990,000 (-28.10%)

$12,503,000 (-52.57%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$42,170,000 (14.98%)

$36,677,000 (47.79%)

$24,817,000 (2.83%)

$24,133,000 (-33.80%)

Invested Capital

$95,232,000 (5.90%)

$89,924,000 (9.71%)

$81,962,000 (4.73%)

$78,261,000 (12.29%)

Working Capital

$15,554,000 (149.14%)

$6,243,000 (-70.10%)

$20,881,000 (-29.21%)

$29,499,000 (22.11%)

Tangible Asset Value

$143,232,000 (14.99%)

$124,563,000 (6.42%)

$117,043,000 (-0.78%)

$117,962,000 (4.80%)

Market Capitalization

$312,271,227 (3.35%)

$302,138,658 (5.12%)

$287,432,311 (38.94%)

$206,870,928 (-31.90%)

Average Equity

$122,999,000 (15.15%)

$106,813,750 (10.01%)

$97,094,000 (2.40%)

$94,820,000 (16.07%)

Average Assets

$166,354,250 (15.11%)

$144,511,500 (23.47%)

$117,043,000 (-0.78%)

$117,962,000 (4.80%)

Invested Capital Average

$97,316,500 (11.33%)

$87,409,500 (6.65%)

$81,962,000 (4.73%)

$78,261,000 (12.29%)

Shares

38,936,562 (1.16%)

38,489,001 (1.23%)

38,020,147 (-4.06%)

39,630,446 (1.24%)